The Supreme Court will hear arguments on March 26 in a case challenging access to abortion drugs and its regulatory approval process, the court announced Monday.
In December, the nation’s highest court upheld several moves by the U.S. Food and Drug Administration (FDA) aimed at making mifepristone tablets easier to obtain and use following a reversal of rulings against the Biden administration and drug companies. They agreed to consider Danko’s appeal. Last year’s Roe v. Wade case.
In reversing Roe v. Wade in June 2022, the Supreme Court ruled in Dobbs v. Jackson Women’s Health Organization that the U.S. Constitution does not guarantee the right to abortion and that the issue could be decided by each state. It was decided that
As a result, 14 states have banned abortions at all stages of pregnancy, with some exceptions, and two others have banned abortions from the moment a fetal heartbeat is detected (approximately 6 weeks into pregnancy). was prohibited.
Republican countries unite with pro-life doctors in fight against Scotus abortion pill
Mifepristone, also known as RU-486, is a drug that is typically used in combination with misoprostol to produce medical abortions and manage early miscarriages during pregnancy. (Getty Images)
The Biden administration and the makers of the drug mifepristone are asking the high court to reverse an appellate ruling that would have cut off access to the drug by mail and imposed other restrictions, even in states where abortion remains legal. There is.
The restrictions include reducing the length of time mifepristone can be used during pregnancy from the current 10 weeks to seven weeks. The nine justices rejected another appeal from abortion opponents that challenged the FDA’s initial approval of mifepristone as safe and effective in 2000.
Federal appeals court restricts access to abortion drug mifepristone, drug remains available
Supreme Court of the United States. (AP Photo/Mariam Zuhaib, File)
Erin Hawley, a lawyer with the civil rights group Alliance Defending Freedom, which is challenging the Biden administration, said the Biden administration “recklessly lifted safety standards that the FDA initially thought were necessary for women using abortion pills. “I’m defending what I did.”
“The FDA’s own labels for these drugs state that approximately 1 in 25 women who take these drugs end up in the emergency room. By eliminating consistent and continuous treatment, more women are exposed to severe, life-threatening suffering from a “threatening condition,” Hawley said in a statement.
Missouri attorney general sues Biden administration for approving mailing of chemical abortion pills
Crowd outside the Supreme Court reacting to Dobbs’ decision. (FOX News Photo/Joshua Commins)
“Regardless of what Americans think about abortion, no one should allow the FDA to force girls to take these high-risk drugs alone,” she added.
CLICK HERE TO GET THE FOX NEWS APP
The Supreme Court will hear arguments in the case called . FDA vs. Hippocratic Medical Alliance Tuesday, March 26th 10am
